Literature DB >> 23629921

Andrographolide protects against cigarette smoke-induced lung inflammation through activation of heme oxygenase-1.

Dongbin Yang1, Weihong Zhang, Laijun Song, Fuyou Guo.   

Abstract

This study was conducted to check whether andrographolide, a bioactive molecule isolated from Andrographis paniculata, could protect against cigarette smoke (CS)-induced lung injury through activation of heme oxygenase-1 (HO-1). Pretreatment with andrographolide (1 mg/kg body weight) markedly attenuated lung inflammation in CS-exposed mice, coupled with reduced numbers of total cells, neutrophils, and macrophages in bronchial alveolar lavage fluid (BALF) and decreased production of cytokine/chemokine into BALF. Furthermore, andrographolide pretreatment increased the expression and activation of HO-1 in the lung of CS-exposed animals. Notably, these histological and biochemical changes induced by andrographolide were blocked by prior administration of zinc protoporphyrin IX (ZnPP; 20 mg/kg body weight), a potent heme oxygenase inhibitor. Moreover, andrographolide-induced phosphorylation of signal transducer and activator of transcription 3 (STAT3) was attenuated by ZnPP treatment in CS-exposed animals. Our data collectively demonstrate that andrographolide confers protection against CS-induced lung inflammation, partially through activation of HO-1 and STAT3.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23629921     DOI: 10.1002/jbt.21483

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  6 in total

1.  Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate.

Authors:  Hongzhi Qiao; Lihua Chen; Tianqi Rui; Jingxian Wang; Ting Chen; Tingming Fu; Junsong Li; Liuqing Di
Journal:  Int J Nanomedicine       Date:  2017-02-07

2.  Andrographolide Protects against HG-Induced Inflammation, Apoptosis, Migration, and Impairment of Angiogenesis via PI3K/AKT-eNOS Signalling in HUVECs.

Authors:  Ming-Xia Duan; Heng Zhou; Qing-Qing Wu; Chen Liu; Yang Xiao; Wei Deng; Qi-Zhu Tang
Journal:  Mediators Inflamm       Date:  2019-10-07       Impact factor: 4.711

3.  Andrographolide Against Lung Cancer-New Pharmacological Insights Based on High-Throughput Metabolomics Analysis Combined with Network Pharmacology.

Authors:  Wen Luo; Li Jia; Jia-Wen Zhang; Dong-Jie Wang; Qiu Ren; Wei Zhang
Journal:  Front Pharmacol       Date:  2021-04-21       Impact factor: 5.810

Review 4.  Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview.

Authors:  Liu-Ying Li; Chuan-Tao Zhang; Feng-Ya Zhu; Gang Zheng; Yu-Fei Liu; Ke Liu; Chen-Hui Zhang; Hong Zhang
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

5.  Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis.

Authors:  Ming Shu; Xiao-Rong Hu; Zuo-An Hung; Dam-Dan Huang; Shun Zhang
Journal:  Mol Med Rep       Date:  2016-02-10       Impact factor: 2.952

Review 6.  Therapeutic Potential of Medicinal Plants and Their Constituents on Lung Inflammatory Disorders.

Authors:  Hyun Pyo Kim; Hyun Lim; Yong Soo Kwon
Journal:  Biomol Ther (Seoul)       Date:  2017-03-01       Impact factor: 4.634

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.